Ethanol (ETOH) is added to unleaded gasoline to decrease environmental levels of carbon monoxide from automobiles emissions. Therefore, addition of ETOH in reformulated fuel will most likely increase and the involuntarily human exposure to this chemical will also increase. This preliminary study was undertaken to evaluate the possible neuromotor effects resulting from acute ETOH exposure by inhalation in humans. Five healthy non-smoking adult males, with no history of alcohol abuse, were exposed by inhalation, in a dynamic, controlled-environment exposure chamber, to various concentrations of ETOH (0, 250, 500 and 1,000 ppm in air) for six hours. Reaction time, body sway, hand tremor and rapid alternating movements were measured before and after each exposure session b y u s i n g t h e C AT S Y S TM 7 . 0 s y s t e m a n d a diadochokinesimeter. The concentrations of ETOH in blood and in alveolar air were also measured. ETOH was not detected in blood nor in alveolar air when volunteers were exposed to 250 and 500 ppm, but at the end of exposure to 1,000 ppm, blood and alveolar air concentrations were 0.443 mg/100ml and 253.1 ppm, respectively. The neuromotor tests did not show conclusively significant differences between the exposed and non-exposed conditions. In conclusion, this study suggests that acute exposure to ethanol at 1,000 ppm or lower or to concentrations that could be encountered upon refueling is not likely to cause any significant neuromotor alterations in healthy males. (J Occup Health 2003; 45:215-222) 
Ethanol (ETOH, ethyl alcohol, ethyl hydrate, C 2 H 6 OH) is used as a fuel additive in the range of 5 to 10% in cars using unleaded gasoline. In specially designed cars, the fuel concentration of ethanol (ETOH) may reach 85% (v/v). It is used as an oxygenant to decrease automobile emissions of carbon monoxide 1) . Considering the efforts to diminish toxic emissions in the environment, ETOH is likely to become a major fuel constituent. Therefore, involuntary exposures to ETOH may rise if ETOH content in fuel increases and it is clear that this new use of ETOH introduces inhalation as a new exposure route for humans. Under common ETOH utilisation conditions, users are also exposed to its vapours and this makes the respiratory system the major exposure route of ETOH, so that it becomes necessary to evaluate the potential effects associated with such ETOH utilization.
The occupational standard limit for ethanol exposure in air is 1,000 ppm (8 h/d, 5 d/wk) for the Occupational Safety and Health Administration (OSHA), the American Conference of Government Industrial Hygienists (ACGIH) and the National Institute of Occupational Safety and Hygiene (NIOSH), based on temporary irritation of the eyes and the respiratory tract at this level of exposure or higher. At higher concentrations, ethanol vapours also induce headaches, fatigue, and sleepiness and affect the central nervous system (CNS). Since ETOH's toxic effects require its penetration into the bloodstream, airborne exposure can be evaluated by measuring blood ETOH concentrations (BAC) or breath alcohol 2) . Endogenous levels of ETOH in blood usually range from 0.02 to 0.15 mg% in normal subjects 3) and the rate of clearance in humans is about 83 mg/kg/h but may reach 127 mg/kg/h in some individual 4) . It is common knowledge that ingestion of ETOH affects the CNS and more particularly the frontal lobes, the occipital lobes and the cerebellum 5, 6) . Recent studies have demonstrated that brain aldehyde dehydrogenase may contribute to the effects of ETOH on motor activity 7) and that exhaled acetaldehyde could be measured and used as an exposure indicator after inhalation exposure of humans to low levels of ETOH (25-1,000 ppm) 8) . Maintenance of standing posture, manual coordination and tremor have long been associated with the assessment of nervous system functions [9] [10] [11] . The use of a quantitative sensorimotor test battery is worthwhile because it reduces subjectivity observed with clinical scale tests. Therefore, results can be used to make interpretations of the performance based on well-established facts 11, 12) . Beuter and colleagues 9) reported that exposure to such substances as manganese and mercury affects the ability of subjects to perform rapid alternating movements such as pronation-supination and flexion-extension. Therefore, diadochokinesia have been shown to provide quantitative information about nervous system status. Moreover, measurement of postural sway and postural tremor becomes at this point a tool for neuronal damage detection and the use of the Sway TM 7.0 is an appropriate way to compare neurological deficits with the clinical tests used for the same purpose 12, 13) . Neuromotor effects after ETOH ingestion have been extensively studied, but effects after inhalation exposure to ETOH are not well established. Jones 3) reported acute alterations in body sway and hand tremor at peak blood concentrations after ingestion of 0.68 g/kg of ETOH in men and no significant impairment when BAC reached 50-70 mg% in the postpeak phase. Kubo and colleagues 14) and Savolainen and Riihimäki 15) also reported changes in body sway in men after ingestion of 2.0-3.5 ml/kg of whisky (40% of alcohol) and 400-800 mg/kg of alcohol, respectively.
Since ETOH concentrations in the air tend to increase, it is likely that human involuntary exposure might also increase. Therefore, it becomes necessary to evaluate the possible neuromotor effects of such exposure. The aim of this preliminary study is to see if acute ETOH exposure at concentrations near or below the current admissible level is likely to affect some sensitive markers of neuromotor disturbance in human volunteers.
Materials and Methods
Subjects: Five healthy right-handed adult men (nonsmokers; age, 22-53 yr) were recruited for this study. The volunteers who gave their informed consent were all social drinkers and had no history of drug or alcohol abuse. A detailed questionnaire was also administrated investigating substance abuse, as well as medical, surgical and psychiatric antecedents to ensure that possible confounders were not introduced. During the entire study, volunteers were instructed to avoid ingestion of ETOH and coffee during the 24 and 12 h preceding the exposures, respectively. Subjects were exposed on five different days (6 h/d; 9h00 to 15h00) to ETOH (0, 250, 500 and 1,000 ppm). All exposures were separated at least by a 24-h period to prevent accumulation of ETOH in the body. Exposures were not run in sequential order (0, 500, 1,000 and 250 ppm). Subjects were continuously under observation during each exposure session and remained seated almost all of the time, although they were free to move in the chamber. This protocol was approved by the Ethics Committee of the Faculty of Medicine (University of Montréal).
Solvents: ETOH (95%) was obtained from Les Alcools de Commerce Inc. and was used to generate ETOH concentrations in the inhalation chamber. ETOH 100% from Sabex Inc. was used to prepare ETOH standard curves (for alveolar air and blood analyses).
Exposure Chamber: Exposures to ETOH were carried out in a dynamic controlled-environment exposure chamber measuring 18.1 m 3 . Purified air, which was introduced from the ceiling at a rate of 5.34 m 3 /min, was temperature (22°C) and humidity-controlled (45%). ETOH atmospheres were generated by the introduction of ETOH by means of an high-pressure liquid chromatography (HPLC) pump (Varian Canada) into a 1-l, three-necked, round-bottomed flask and mixed with clean, compressed air and then swept by aspiration into the inlet duct of the chamber. The concentration of ETOH in the chamber was monitored by automatic sampling of 1 ml of chamber atmosphere at intervals of 10 min into a gas chromatograph (Varian Chrompack 3800) equipped with a flame-ionisation detector. The column (DB-Wax, 30 m, 0.53 mm I.D.) was heated at 75°C whereas the temperature of the injection port and detector was set at 180°C and 250°C, respectively. ETOH standards were prepared by using 10L Tedlar ® bags. In addition, continuous monitoring of ETOH was carried out with an infrared spectrophotometer (MIRAN 1-A).
Measurement of ETOH in Blood and Alveolar Air:
The concentration of ETOH in blood, taken from the antecubital vein, during exposure (at 3 and 6 h) was measured by a head-space gas chromatographic technique under the same chromatographic conditions as described above. Calibration standards containing ETOH (0.084-1.678 mg %) were prepared by adding ETOH to human control blood. The alveolar air concentration of ETOH was measured at 0, 3, 4.5 and 6 h by injecting 1 ml of alveolar air collected in 3-L Tedlar ® bags into the chromatograph.
Evaluation of Neuromotor Functions:
Neuromotor activity was examined with a diadochokinesimeter (Doco Microsystèmes Inc. Montreal, Canada) and a standard test battery (CATSYS 7.0 System ® ; Danish Product Development Co., Denmark). The tests were administered before and immediately after each exposure session. Volunteers had a few seconds to practise with the apparatus before the first trial of the day to become familiar with the testing procedures.
The CATSYS 7.0 System ® is a portable system including a datalogger used to quantify different neuromotor functions such as tremor, reaction time and postural sway. Postural tremor was measured successively for each hand for 24 s and repeated two times. Subjects had to hold a light stylus (Tremor ® Pen) horizontally, parallel to the abdomen at approximately 10 cm in front of the navel and with the elbow joint bent at a right angle and free of the body. During the recording, subjects looked at the tip of the stylus, breathed normally and relaxed. The stylus recorded hand vibrations, and information was displayed in realtime in a time axis plot on the computer screen. Five key measures were calculated: Tremor Intensity (I), Centre Frequency (F50), Frequency dispersion (FD), modified Harmonic Index (HI) and tremor index (TI) 16) . A short definition of each characteristic is shown in Table 1 .
Reaction time was measured with a hand switch activated by the thumb with a sound stimulus coming from the datalogger. The test was done with both hands for 70 s each time. Parameters calculated from this test were mean reaction time (RT) and standard deviation (SD).
The Sway Analysis Test System (SWAY TM 7.0) is a platform containing 3 orthogonal strain-gauge devices. The subjects had to stand on the platform, feet at 1 cm from one another, with their arms at the sides, the body slightly tilted forward with body support coming from the front part of their feet. Subjects had to look at a picture placed at 6 feet in front of them, or keep their eyes closed. For each test, postural sway was measured for 75 s (a 10 s start-up period, a 60 s recording period and a 5 s run-out period). Sway parameters calculated included: Transversal Sway (TS), Sagittal Sway (SS), Sway Area (SA) and Sway Velocity (SV). Table 1 gives a definition of these characteristics.
The Diadiochokinesimeter is a system used to quantify rapid alternating movements (RAMs) in a quick and simple way. This system records both hands, and the multidirectional joint connecting the rods to the system allows some subjects with movement disorders to still be able to complete the test. For a more complete description of the method, refer to Beuter and colleagues 16) . Subjects sat in front of the system and held the foam spheres while keeping the elbows close to the trunk and flexed at about 90°. Subjects rotated the spheres at natural cadence (twice), then as fast as possible with each hand while the other hand was kept immobile (twice) and finally, at fast cadence with both hands (twice). Each trial lasted 5 s and was followed by a rest period of about 20 s. Four characteristics were calculated from each recording: Range, Velocity, Maximum Slope and Coherence. Detailed definitions of these characteristics are shown in Table 1 .
Statistics:
The effect of ETOH exposure on neuromotor activity was evaluated with the Wilcoxon signed-rank test for paired data. The level of significance was set at 0.05.
Results

ETOH in Blood and Alveolar air:
Whereas ETOH was not detected in the blood of volunteers exposed to 250 and 500 ppm, the blood concentrations measured at 3 and 6 h during exposure to 1,000 ppm were 0.229 mg% and 0.443 mg%, respectively (Fig. 1a) . ETOH in alveolar air was measured only in samples taken during the 1,000 ppm exposure. As can be seen in Fig. 1b , the concentration reached a steady-state 3 h after the start of exposure and ranged from 241 ± 21.5 ppm to 249 ± 28.4 ppm (mean ± SD).
Neuromotor Activity: The raw data obtained from the neuromotor tests are shown in Tables 2 and 3 . The statistical test used showed significant results for velocity of alternating movements (diadochokinesia) with the right hand at maximal speed, for harmonic index with the right hand, for sway velocity with closed eyes and for tremor index with the right hand. The first three results were obtained at 500 ppm (p=0.043), but no significant results could be observed at 1,000 ppm. Significant changes were observable for the Tremor Index at 0 ppm but at no other ETOH concentration. Results of the Wilcoxon sign rank tests are shown in Table 4 .
Discussion
This preliminary study was undertaken to see whether or not acute exposure to ETOH by inhalation at concentrations similar to or below 1,000 ppm is likely to produce small neuromotor effects. Blood concentrations measured at 3 and 6 h during exposure to 1,000 ppm were 0.229 mg% and 0.443 mg%, respectively. This is far below the range of blood alcohol levels (50-150 mg %) that is usually associated with mild ethanol intoxication. The results also showed that the absorption from lungs was approximately 75% which is a higher value than the one usually reported (≈62%) by Lester and Greenberg 17) in subjects exposed to concentrations ranging from 5,850 to 10,265 ppm of ETOH and used by Pastino and colleagues 1) in their physiologically based pharmacokinetics (PBPK) model. Therefore, it appears that the fraction of ETOH absorbed in the lungs is higher at lower exposure concentrations.
ETOH diminishes the flow of nerve action potentials and can therefore be regarded as a central depressant, causing a delay of reflexes and reactions 18) . This mechanism can explain the significant decrease in Fig. 1 . ETOH concentrations in blood (a) and expired air (b) in five men after a 6-h inhalation exposure to 1,000 ppm of ETOH. diadochokinesia velocity (maximal speed) and Harmonic Index (right hand) and for the increasing sway velocity (closed eyes) observed after the 500 ppm exposure. Nevertheless, since these neuromotor changes were not observed after the 1,000 ppm exposure, these results should be interpreted cautiously. Concerning the postural tremor, Jones 3) reported that blood concentrations had to be higher than 50-70 mg% to produce significant changes in the postural tremor in men who ingested 0.68 g/kg of ETOH. Nevertheless, the test battery used by Jones was quite different (i.e. less sensitive) from the one used in the present study, and the blood concentrations measured were still about 113-160 times lower than those needed to produce such an effect. The decrease in the Tremor Index (right hand) observed at 0 ppm was not considered as significant since 1) this neuromotor alteration was not observed at higher exposure concentrations and 2) the 0 ppm exposure was the first of all exposures and we concluded that it is possible that subjects were not completely familiar with this procedure at the time. It should also be noted that the Tremor Index is an overall summary index which incorporates Tremor Intensity (RMS), Median Frequency, Standard Deviation of median frequency and Harmonic Index transformed in z-scores,so that any value deviating significantly from the norm established by the manufacturer will contribute a smaller than usual amount to the Tremor index 12, 19) . (For the equations used, see Edwards and Beuter, 1999 19) ). We can further conclude that since all parameters deviated slightly from the norm at 0 ppm, the overall sum of all parameters was lower than what was expected, resulting in a significant change in the Tremor Index. The Harmonic Index compares the tremor frequency pattern with the pattern of a single harmonic oscillator which would have a harmonic index of 1. This index decreases when the tremor is composed of many oscillations as is physiological tremor. It quantifies the regularity of the oscillations by means of concentrations of spectral power in narrow frequency ranges. It is the centre of mass of the sorted spectrum 19) . Therefore, it can be understood that oscillations were less regular at the end of the 500 ppm than before exposure, but since the decrease in the Harmonic Index was not observed at 1,000 ppm, it was not considered to be a significant neuromotor change. It has also been proposed that when ETOH is ingested, blood concentrations have to reach 60 mg% ml for a significant increase in body sway to be observed 14) . Blood levels measured in the present study are far below those values and this may explain why body sway was not altered by exposure to ETOH in this dose range.
Maximum movement speed tends to exacerbate problems more readily than normal speed because the neuromuscular system is approaching its functional limits 9, 16) . It is believed that differences invisible at normal cadence become clear when the neuromuscular system approaches its functional limits and coordinating the two hands at fast cadence is likely to exacerbate problems more than using only one hand at a time. It was suggested that although the RAMs measure is a precise and reliable method, the analysis of the results may not be sophisticated enough to detect the subtle differences that characterize early signs of neurotoxicity 9) . It is important to mention that the degree of the neuromotor changes will depend on the nature of the performance task and the individual's tolerance of the effects of ETOH on the CNS 3, 20) . One of the major problems in assessing motor functions is the high intraindividual variation, and in the present study (n=5) this variation may have played a significant role. On the other hand, since exposure to 1,000 ppm of ETOH does not induce significant neuromotor changes, it is unlikely that exposure encountered on refuelling, at concentrations up to 43 ppm may induce acute neuromotor effects in normal populations 1) . Nevertheless, it is possible that tendencies encountered in some of the neuromotor tests become significant in more sensitive populations, in plant workers with physical activity during work which is known to enhance ventilation rate and therefore absorption, or as a result of repeated exposures.
In conclusion, this study showed that acute exposure to ethanol at 1,000 ppm or lower or to concentrations that could be encountered on refuelling is not likely to cause any significant neuromotor changes in healthy males, but in the near future, it would be worthwhile to assess the chronic neuromotor effects of ethanol after inhalation exposure in the perspective of public health.
